1332 — Touyun Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Touyun Biotech, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	199	254	94	144	36
Net Total Accounts Receivable
Net Total Receivables	128	171	132	132	69.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	365	469	268	322	162
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	52.7	172	436	381	311
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	886	972	1,025	888	607
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	332	407	530	410	381
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	345	484	555	624	608
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	541	488	470	264	-0.848
Total Liabilities & Shareholders' Equity	886	972	1,025	888	607
Total Common Shares Outstanding